Articles

ICSI has notified that candidates who have registered under the CS Executive old syllabus (2017) can switch over to CS Executive new syllabus (2022) comprising 7 papers.

ICSI Guidelines for Switchover from old to new syllabus 2022 for CS 2023 Executive Exam

A tax residence certificate issued by authorities of a foreign nation cannot be questioned by tax authorities. This was mentioned in a recent judgement issued by ITAT Delhi.

Tax Residency Certificate cannot be questioned by Authorities

Notifications

The Central Board of Direct Taxes (CBDT) has instructed that the Procedure for remedial action where Revenue Audit Objection is accepted should be followed very carefully by the Income Tax Officers. The Process has been prescribed in Instruction No. 7/2017.

Procedure for "remedial action where Revenue Audit Objection is accepted" to be followed carefully: CBDT

The Calculator for revised due date of filing refund application u/s 54 after considering Notification No 13/2022-CT Dated 05.07.2022 (i.e COVID Period Exclusion).

GST: Excel Calculator for Revised Due Date of Filing Refund Application u/s 54

News

Union government is expected to begin settling complaints launched by National Pharmaceutical Pricing Authority for pharmaceutical businesses under Vivad se Vishwas scheme 2.

Centre may choose Penalty Settlement for Pharma Companies Cases Under Vivad Se Vishwas Scheme 2

DGGI has sent letters of inquiry to roughly 10-12 mutual fund institutions, asking details of transactions that were determined to be suspicious, as per sources reported.

Explore Our Blogs

Stay updated with the latest insights, tips, and industry trends from our experts

ICSI Guidelines for Switchover from old to new syllabus 2022 for CS 2023 Executive Exam

Tax Residency Certificate cannot be questioned by Authorities

Procedure for "remedial action where Revenue Audit Objection is accepted" to be followed carefully: CBDT

GST: Excel Calculator for Revised Due Date of Filing Refund Application u/s 54

Centre may choose Penalty Settlement for Pharma Companies Cases Under Vivad Se Vishwas Scheme 2

GST Intelligence Investigates at least 10 Mutual Fund Houses for Fraud Expense Claims